BluCon Biotech, a German biotech company, and LG Chem, a leading chemical company, have entered into an investment agreement to scale up and commercialize BluCon Biotech’s proprietary technology to supplement LG Chem´s bio-economy portfolio BluCon Biotech’s technology has the potential to be a disruptive game changer in the world's plastics market by using direct fermentation of lignocellulosic feedstock to lactic acid to achieve bioplastic PLA that is price-competitive with fossil-based plastics, contributing to a sustainable circular bio-economy BluCon Biotech and LG Chem agreed to work together on a novel process for converting non-food lignocellulosic feedstocks into high purity lactic acid, a precursor for bio-based and biodegradable plastics.
BluCon Biotech GmbH, ein deutsches Biotech-Unternehmen, und LG Chem Ltd., ein führender koreanisches Chemiekonzern, haben eine Investitionsvereinbarung geschlossen, um die patentrechtlich geschützte Technologie von BluCon Biotech zu erweitern und zu kommerzialisieren und um das Bioökonomie-Portfolio
von LG Chem zu ergänzen.
Consolidated bioprocessing (CBP) of lignocellulosic biomass to l-lactic acid using thermophilic cellulolytic/
hemicellulolytic bacteria provides a promising solution for efficient lignocellulose conversion without the need for additional cellulolytic/hemicellulolytic enzymes. Most studies on the mesophilic and thermophilic CBP of lignocellulose to lactic acid concentrate on cultivation of non-cellulolytic mesophilic and thermophilic bacteria at temperatures of 30–55 °C with external addition of cellulases/hemicellulases for saccharification of substrates
BluCon Biotech erhält Förderung im Rahmen der Maßnahmen aus der Dialogplattform Industrielle Bioökonomie
Das BIO Deutschland-Mitglied BluCon Biotech GmbH hat am 24. November in Köln einen Zuwendungsbescheid über 931.111 Euro vom Bundesministerium für Wirtschaft und Energie (BMWi) erhalten.
